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An efficient synthesis of some new 2-aryl-5-(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 7a-e, has been 
accomplished through oxidative cyclization of 2-(4-nitrophenylamino)-N'-(substituted benzylidene) thiazole-4-carbohydrazides  
6a-e using an ecofriendly oxidant, (diacetoxyiodo)benzene at ambient temperature. The structures of the synthesized oxadiazole-
thiazole hybrid compounds have been characterized by elemental and spectral (IR, 1H and 13C NMR, and MS) analysis. The 
reaction can tolerate a wide range of aldehydes to afford the corresponding unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles. The 
mild reaction conditions, relatively benign nonmetallic oxidant and short reaction time are noteworthy advantages of this 
methodology. 
Keywords: 2-Aryl-5-(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles, 2-(4-nitrophenylamino)-N'-arylidenethiazole-4-
carbohydrazide, (diacetoxyiodo)benzene, oxidative cyclization, oxadiazole-thiazole hybrid 
Recently there has been an upsurge of interest in 
chemistry of 1,3,4-oxadiazole scaffold as useful 
synthons for the synthesis of value-added chemical 
entities possessing high structural diversity
1,2
. This 
privileged structural motif forms an integral part of 
various bioactive compounds and clinically important 
drugs such as Nesapidil, Furamizole, Zibotentan and 
Raltegravir (Figure 1). Compounds containing 1,3,4-
oxadiazole core have extensive application in diverse 
areas ranging from organic light-emitting diodes, 
photoluminescence, liquid crystals, molecular wires, 
agrochemicals, polymers to medicinal chemistry
3-9
. 
Further, 1,3,4-oxadiazoles as bioisosteres of ester and 
carboxamide functionalities, can interact with a number 
of biological targets by forming hydrogen bonding 
interactions thereby enhancing the pharmacological 
activity of the candidate. 
1,3-Thiazole and its derivatives are versatile leading 
molecules in medicinal chemistry due to their diverse 
syntheses and potential in drug design and 
development
10,11
. Thiazole scaffold is present naturally 
in vitamin B1, antibiotic Penicillin, alkaloid 
Bacillamide and in various synthetic pharmaceutical 
drugs including Fanetizole (immunomodulator), 
Meloxicam (anti-inflammatory), Sulfathiazole 
(antimicrobial), Bleomycin (anticancer), Pramipexole 
(antidepressant), Nizatidine (antiulcer) and Ritonavir 
(HIV-protease inhibitor). The integration of two or 
more pharmacophores in one chemical entity is a 
promising strategy in the search for novel therapeutic 
agents with higher efficacy and lower toxicity
12,13
. In 
this context, 2-pyridinyl substituted thiazolyl-5-aryl-
1,3,4-oxadiazoles I, and II have displayed significant 
antitubercular activity against Mycobacterium Bovis 
BCG with MIC value of 2.65 μg/mL and 2.56 μg/mL, 
respectively
14
. Oxadiazole derivative III incorporating 
thiazole nucleus exhibited in vitro anticancer activity 
against two human cancer cell lines, MDA-MB231 and 
HT-29 and arrested cell cycle in Go/G1 phase on both 
cell lines
15
. In a docking study, interaction of several 
thiazolyl-1,3,4-oxadiazole derivatives on lanosterol 
14α-demethylase (CYP51), target enzyme in the design 
of antifungal agents, was reported
16
. Thiazole clubbed 
1,3,4-oxadiazole derivatives IV have found to exhibit 
potent antimicrobial activities
17
. Provoked by these 
observations, an attempt to design a series of new 
molecular hybrids having oxadiazole and thiazole 
pharmacophores using molecular hybridization 
approach has been put forward. 
 
In view of significant roles of 1,3,4-oxadiazole ring 
in medicinal chemistry, drug design and material 
————— 
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science, a number of synthetic approaches have been 
developed for symmetrical and asymmetrical  
2,5-disubstituted 1,3,4-oxadiazoles (Scheme I). The 
commonly used synthetic routes for 1,3,4-oxadiazoles 
involve: (i) intermolecular condensation of 
acylhydrazide with carboxylic acid in presence of 
dehydrating reagents such as phosphorous oxychloride, 
polyphosohoric acid, acetic anhydride under harsh 
reaction conditions, (ii) cyclodehydration of N,N'-
diacylhydrazines with thionyl chloride/ POCl3/ 
triphenylphosphine oxide-triflic anhydride/ 
zirconium(IV) chloride, (iii) reaction of acylhydrazide 
with excess of acid chloride in hexamethyl-
phosphoramide (HMPA) and then microwave 
irradiation, (iv) oxidative cyclization of  
N-acylhydrazones using various oxidizing agents viz. 
lead tetraacetate, lead(IV) oxide, cerric ammonium 
nitrate (CAN), chloroamine T, trichloroisocyanuric acid, 
mercuric acetate, potassium permanganate, mercury(II) 
oxide-iodine or through electrochemical methods,  
(v) reaction of arylhydrazide with orthosters using 
catalytic NH4Cl, (vi) reaction of acylhydrazide with  
α-bromonitroalkanes, (vii) Huisgen reactions of 
tetrazoles with acid chlorides
7, 18-20
. 
 
The dehydrative cyclization and numerous other 
methods have limitations due to harsh conditions, 
highly toxic and corrosive reagents, longer reaction 
times and high temperature. On the other hand, 
oxidative cyclization of N-acylhydrazones, versatile 
precursors to furnish asymmetrical oxadiazoles, has 
also been reported by milder and environmentally 
sustainable reagents such as hypervalent iodine 
reagents ((diacetoxyiodo)benzene (DIB) and 
bis(trifluoroacetoxy)iodobenzene (BTI))
21
 and 
molecular iodine
22
. 
Immense biological activities associated with 1,3, 
4-oxadiazole and 1,3-thiazole derivatives and our 
ongoing interest on efficacy of hypervalent iodine 
 
 
Figure 1 — Representative bioactive molecules containing 1,3,4-oxadiazole core 
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reagents in green organic synthesis
23-28
, impelled us to 
synthesize a series of 2-aryl-5-(2'-(4-nitrophenyla 
mino)thiazol-4'-yl)-1,3,4-oxadiazoles 7a-e having both 
thiazole and oxadiazole pharmacophores and diverse set 
of aromatic substitutions at position-2 of oxadiazole core 
in one molecular framework through a highly efficient, 
facile and ecofriendly route (Figure 2). 
 
Results and Discussion 
The hybrid 1,3,4-oxadiazole-1,3-thiazole compounds 
7a-e were synthesized according to the reaction 
sequence as framed in the Scheme II. Initially, ethyl  
α-bromopyruvate 1 obtained by bromination of ethyl 
pyruvate in presence of dry CO2
29
, was condensed with 
p-nitrophenylthiourea 2 in ethanol followed by 
neutralization with saturated sodium bicarbonate 
solution to afford ethyl-2-(4-nitrophenylamino)thiazole-
4-carboxylate 3 via Hantzsch’s thiazole synthesis. In the 
next step, compound 3 was refluxed with hydrazine 
hydrate in dimethylsulfoxide to obtain 2-(4-
nitrophenylamino)thiazole-4-carbohydrazide 4. A 
solution of 4 in MeOH-THF (1:1) was refluxed with 
differently substituted benzaldehydes 5a-e in presence  
of two drops of acetic acid for about 2-3 h to afford  
2-(4-nitrophenylamino)-Nʹ-arylidenethiazole-4-carbohy-
drazide 6a-e in 84-88% yields. The oxidative cyclization 
of 6a-e was achieved with 1.1 equiv of DIB in 
dimethylformamide by stirring at RT for 2 h. The usual 
work up of the reaction yielded single product, 2-aryl-5-
(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 
7a-e in 78-85% yield (Scheme II). The structures of all 
the newly synthesized compounds 6a-e and 7a-e were 
 
 
Scheme I — Reterosynthetic approach to 2,5-disubstituted 1,3,4-oxadiazoles 
 
 
 
Figure 2 — Design of oxadiazole-thiazole hybrids using molecular hybridization of pharmacophores 
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characterized by spectral data such as IR, NMR (
1
H and 
13
C), mass and elemental analyses. 
 
The IR spectra of 2-(4-nitrophenylamino)-N'-
arylidenethiazole-4-carbohydrazides 6a-e displayed 
absorption bands in the range 3374-3397 cm
−1 
and 3270-
3285 cm
−1 
which were attributed to the –NH stretch and 
–NH stretch of secondary amide, respectively. The 
absorption band for –C=O stretch was observed in the 
range 1662-1685 cm
−1
. The 
1
H NMR spectra of 6a-e 
displayed two characteristic singlets of one proton 
intensity each at δ 7.86-7.99 attributed to the thiazole-5-
H and at δ 8.59-8.65 attributed to imine group (N=CH) 
proton, besides the signals for phenyl groups in the 
aromatic region. Two more singlets of one proton 
intensity have also been observed at δ 11.11-11.20 and 
at δ 11.37-11.49, corresponding to secondary amino  
(-NH) and secondary amide (−CONH) groups, 
respectively. The 
13
C NMR spectra of carbohydrazides 
6a-e displayed characteristic signal for C5 carbon of 
thiazole ring in the range at δ 116.47-116.82. Two 
signals ranging from δ 156.91-160.54 and δ 140. 
52-140.55 have been assigned to carbonyl group of 
amide and carbon of imino group, respectively. 
The IR spectra of 2-aryl-5-(2'-(4-
nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 7a-
e displayed one absorption band ranging from 3378-
3394 cm
−1
 for –NH stretch. Disappearance of 
absorption bands for –NH and –C=O stretch of 
secondary amide indicated the cyclization of 
carbohydrazides 6a-e to oxadiazoles 7a-e. In the 
1
H NMR spectra of 7a-e, one proton corresponding to 
thiazole-5-H resonated at δ 7.96-8.12 i.e. somewhat 
deshielded compared to that observed at δ 7.86-7.99 in 
6a-e. Disappearance of two singlets at δ 8.59-8.65 and 
at δ 11.37-11.49 of 6a-e confirmed the oxidative 
cyclization of carbohydrazides 6a-e to oxadiazoles 7a-
e. Also, 7a-e displayed a singlet of one proton intensity 
at δ 11.18-11.22 due to –NH group besides the signals 
for phenyl groups in the aromatic region. In the 
13
C NMR spectrum of 7a, characteristic signals for C2 
and C5 carbons of oxadiazole ring appeared at δ 163.54 
and δ 163.07, respectively. The signal at δ 116.39 has 
been assigned to C5 carbon of thiazole ring. 
 
The plausible mechanism of this transformation is 
outlined in Scheme III. First step involves the 
electrophilic attack of IBD on hydrazone 6a-e followed 
 
 
Scheme II — Synthesis of 2-aryl-5-(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 7a-e 
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by exchange of an acetoxy ligand of IBD to form 
another hypervalent iodine intermediate A. The 
cyclization of intermediate A occurred by intramolecular 
attack of carbonyl oxygen to form the intermediate B, 
which undergoes acetate catalyzed intramolecular 
reductive elimination of iodobenzene and loss of one 
molecule of acetic acid to give the product 7a-e. 
 
Material and Methods 
p-Nitroaniline and ethyl pyruvate were purchased 
from Spectrochem Pvt. Ltd. p-Nitrophenylthiourea was 
prepared by heating p-nitroaniline with ammonium 
thiocyanate in acidic medium following the reported 
procedure
30
. Melting points were determined in open 
capillaries in electrical apparatus and are uncorrected. 
Infrared spectra were recorded on IR M-500 
spectrophotometer (Buck Scientific Inc, Norwalk, CT) 
in KBr pellets (νmax in cm
−1
). 
1
H and 
13
C NMR spectra 
were recorded in CDCl3 or DMSO on a Bruker 
instrument at 300 MHz and 75 MHz, respectively. 
Chemical shifts were recorded as δ values and 
expressed in parts per million (ppm) downfield from 
TMS as an internal reference. Coupling constants (J) 
are given in Hertz (Hz). Mass spectra were measured in 
ESI
+
 mode on a Kratos MS-50 spectrometer at MS 
Facilities at SAIF, Panjab University, Chandigarh, 
India. The compounds gave satisfactory analytical 
results (within ± 0.5 of the theoretical values). The 
reactions were monitored by TLC carried out on 
precoated silica gel plates. 
 
Experimental Section 
 
Preparation of ethyl-2-(4-nitrophenylamino)thiazole-4-carboxylate, 3 
To an ethanolic solution (30 mL) of α-bromoethyl 
pyruvate 1 (2.14 g, 11 mmol), p-nitrophenylthiourea 2 
(1.97 g, 10 mmol) was added and the mixture was 
allowed to reflux for 5-6 h. The solvent was distilled 
off and the reaction mixture was poured in water 
followed by neutralization with saturated sodium 
bicarbonate solution. The solid so obtained was 
filtered, washed with water and recrystallized with 
ethanol to afford the desired product 3. m.p.  
194-195ºC. Yield 76%. IR (KBr): 3270 (N-H), 1730 
cm
−1
 (C=O ester); 
1
H NMR (300 MHz, DMSO-d6): δ 
1.31 (t, 3H, J = 7.2 Hz, -CH3), 4.29 (q, 2H, J = 7.2 Hz, -
CH2), 7.83-7.88 (m, 2H, Ph), 7.97 (s, 1H, thiazole-5-H), 
8.23-8.28 (m, 2H, Ph), 11.16 (s, 1H, NH). 
 
Preparation of 2-(4-nitrophenylamino)thiazole-4-
carbohydrazide, 4 
To a solution of ethyl-2-(4-nitrophenylamino) 
thiazole-4-carboxylate 3 (2.93 g, 10 mmol) in DMSO 
 
 
Scheme III — A plausible mechanism for formation of 2-aryl-5-(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 7a-e from 
reaction of 6a-e with DIB 
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(25 mL), hydrazine hydrate (0.6 mL, 11 mmol) was 
added. The mixture was allowed to reflux for 2 h. The 
solvent was distilled off and reaction mixture was 
poured in water. The solid thus obtained was filtered, 
washed with water and dried in air to afford compound 
4. m.p. 178-180ºC. Yield 72%. IR (KBr): 3386, 3374, 
3285, 1656 cm
−1
 (C=O); 
1
H NMR (300 MHz, DMSO-
d6): δ 7.74 (s, 1H, thiazole-5-H), 7.96-8.03 (m, 2H, Ph), 
8.16-8.23 (m, 2H, Ph), 9.63 (s, 1H, NH), 11.12 (s, 1H, 
NH). 
 
General procedure for the synthesis of 2-(4-
nitrophenylamino)-N'-(substituted benzylidene) 
thiazole-4-carbohydrazides, 6a-e 
A solution of 2-(4-nitrophenylamino)thiazole-4-
carbohydrazide 4 (2.79 g, 10 mmol) and appropriately 
substituted benzaldehyde 5a-e (11 mmol) in 20 mL 
MeOH-THF (1:1) was refluxed in the presence of two 
drops of acetic acid for 2-3 h. The solvent was 
evaporated in vacuum to half of its volume and cooled 
to RT. The solid thus obtained was filtered, washed 
with ethanol and dried in air to afford 6a-e. 
2-(4-Nitrophenylamino)-N'-(benzylidene)thiazole-
4-carbohydrazide, 6a: m.p. >280ºC. Yield 84%. IR 
(KBr): 3386 (N-H), 3274 (N-H amide), 1685 cm
−1
 
(C=O); 
1
H NMR (300 MHz, DMSO-d6): 7.44-7.48 
(m, 3H, Ph-3', 4', 5'-H), 7.78 (d, 2H, J = 8.1 Hz, Ph-
2", 6"-H), 7.86 (s, 1H, thiazole-5-H), 7.99-8.03 (m, 
2H, Ph-2′, 6′-H), 8.23 (d, 2H, J = 8.1 Hz, Ph-3", 5"-
H), 8.65 (s, 1H, CH), 11.11 (s, 1H, NH, exchangeable 
with D2O), 11.37 (s, 1H, NH, exchangeable with 
D2O); 
13
C NMR (75 MHz, DMSO-d6): δ 116.73  
(C-5), 125.21 (2C, Ph-2′, 6′), 127.11 (2C, Ph-2′′, 6′′), 
128.61 (2C, Ph-3′, 5′), 129.03 (Ph-4′), 129.95 (Ph-1′), 
134.20 (Ph-1′′), 140.55 (CH=N), 144.82 (2C, Ph-3′′, 
5′′), 146.28 (Ph-4′′), 148.92 (C-4), 156.91 (C=O), 
162.05 (C-2); MS: (m/z) 368.04 ([M+H]
+
). Anal. 
Calcd for C17H13N5O3S: C, 55.58; H, 3.57; N, 19.06. 
Found: C, 55.24; H, 3.59; N, 19.12%. 
 
2-(4-Nitrophenylamino)-N'-(p-methylbenzylidene) 
thiazole-4-carbohydrazide, 6b: m.p. >280ºC. Yield 
84%. IR (KBr): 3374 (N-H), 3270 (N-H amide), 1674 
cm
−1
 (C=O); 
1
H NMR (300 MHz, DMSO-d6): δ 2.36 
(s, 3H, 4'-CH3), 7.30 (d, 2H, J = 7.8 Hz, Ph-3′, 5′-H), 
7.66 (d, 2H, J = 8.1 Hz, Ph-2", 6"-H), 7.90 (s, 1H, 
thiazole-5-H), 8.00 (d, 2H, J = 7.8 Hz, Ph-2′, 6′-H), 
8.25 (d, 2H, J = 8.1 Hz, Ph-3", 5"-H), 8.59 (s, 1H, 
CH), 11.19 (s, 1H, NH, exchangeable with D2O), 
11.38 (s, 1H, NH, exchangeable with D2O); 
13
C NMR 
(75 MHz, DMSO-d6): δ 25.62 (CH3), 116.47 (C-5), 
124.68 (2C, Ph-2′, 6′), 127.74 (2C, Ph-3′, 5′), 128.95 
(2C, Ph-2′′, 6′′), 130.34 (Ph-1′), 134.61 (Ph-1′′), 
137.62 (Ph-4′), 140.55 (CH=N), 143.57 (2C, Ph-3′′, 
5′′), 146.82 (Ph-4′′), 148.65 (C-4), 158.92 (C=O), 
162.42 (C-2); MS: (m/z) 382.10 ([M+H]
+
). Anal. 
Calcd for C18H15N5O3S: C, 56.68; H, 3.96; N, 18.36. 
Found: C, 56.72; H, 4.09; N, 18.61%. 
 
2-(4-Nitrophenylamino)-N'-(p-chlorobenzylidene) 
thiazole-4-carbohydrazide, 6c: m.p. 253-255ºC. Yield 
88%. IR (KBr): 3397 (N-H), 3278 (N-H amide), 1682 
cm
−1
 (C=O); 
1
H NMR (300 MHz, DMSO-d6): δ 7.55 
(d, 2H, J = 8.4 Hz, Ph-3′, 5′-H), 7.79 (d, 2H, J = 8.1 
Hz, Ph-2", 6"-H), 7.92 (s, 1H, thiazole-5-H), 8.03 (d, 
2H, J = 8.4 Hz, Ph-2′, 6′-H), 8.25 (d, 2H, J = 8.1 Hz, 
Ph-3", 5"-H), 8.63 (s, 1H, CH), 11.20 (s, 1H, NH, 
exchangeable with D2O), 11.49 (s, 1H, NH, 
exchangeable with D2O); 
13
C NMR (75 MHz, DMSO-d6): 
δ 116.82 (C-5), 121.47 (2C, Ph-2′, 6′), 126.52 (2C, 
Ph-3′, 5′), 128.49 (Ph-4′), 128.88 (2C, Ph-2′′, 6′′), 
130.62 (Ph-1′), 134.92 (Ph-1′′), 140.54 (CH=N), 
142.82 (2C, Ph-3′′, 5′′), 146.28 (Ph-4′′), 147.54 (C-4), 
160.54 (C=O), 161.92 (C-2); MS: (m/z) 402.05 
([M+H]
+
)/404.04 ([M+H+2]
+
), (3:1). Anal. Calcd for 
C17H12ClN5O3S: C, 50.81; H, 3.01; N, 17.43. Found: 
C, 50.97; H, 3.30; N, 17.33%. 
 
2-(4-Nitrophenylamino)-N'-(p-bromobenzylidene) 
thiazole-4-carbohydrazide, 6d: m.p. 220-222ºC. Yield 
85%. IR (KBr): 3386 (N-H), 3285 (N-H amide), 1662 
cm
−1
 (C=O); 
1
H NMR (300 MHz, DMSO-d6): δ 7.69  
(d, 2H, J = 8.1 Hz, Ph-3′, 5′-H), 7.87 (d, 2H, J = 8.1 Hz, 
Ph-2", 6"-H), 7.99 (s, 1H, thiazole-5-H), 8.01 (d, 2H, J = 
8.1 Hz, Ph-2′, 6′-H), 8.24 (d, 2H, J = 8.1 Hz, Ph-3", 5"-H), 
8.62 (s, 1H, CH), 11.13 (s, 1H, NH, exchangeable with 
D2O), 11.44 (s, 1H, NH, exchangeable with D2O); 
13
C NMR (75 MHz, DMSO-d6): δ 116.75 (C-5), 120.28 
(2C, Ph-2′, 6′), 123.40 (Ph-4′), 125.28 (2C, Ph-3′, 5′), 
128.91 (2C, Ph-2′′, 6′′), 130.06 (Ph-1′), 133.48 (Ph-1′′), 
140.52 (CH=N), 142.47 (2C, Ph-3′′, 5′′), 146.42  
(Ph-4′′), 147.65 (C-4), 160.45 (C=O), 161.75 (C-2); 
MS: (m/z) 445.99 ([M+H]
+
)/447.98 ([M+H+2]
+
), (1:1). 
Anal. Calcd for C17H12BrN5O3S: C, 45.75; H, 2.71; N, 
15.69. Found: C, 45.49; H, 2.51; N, 15.86%. 
 
2-(4-Nitrophenylamino)-N'-(p-fluorobenzylidene) 
thiazole-4-carbohydrazide, 6e: m.p. >280ºC. Yield 
85%. IR (KBr): 3394 (N-H), 3280 (N-H amide), 1668 
cm
−1
 (C=O); 
1
H NMR (300 MHz, DMSO-d6): δ  
7.30-7.35 (m, 2H, Ph-3′, 5′-H), 7.82 (d, 2H, J = 8.1 Hz, 
Ph-2", 6"-H), 7.91 (s, 1H, thiazole-5-H), 7.99-8.02 (m, 2H, 
Ph-2′, 6′-H), 8.25 (d, 2H, J = 8.1 Hz, Ph-3", 5"-H), 8.63 
(s, 1H, CH), 11.20 (s, 1H, NH, exchangeable with D2O), 
11.46 (s, 1H, NH, exchangeable with D2O); 
13
C NMR  
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(75 MHz, DMSO-d6): δ 116.82 (C-5), 120.44 (2C,  
Ph-3′, 5′), 128.68 (2C, Ph-2′, 6′), 128.94 (2C, Ph-2′′, 6′′), 
131.74 (Ph-1′), 134.47 (Ph-1′′), 140.55 (CH=N), 143.55 
(2C, Ph-3′′, 5′′), 146.28 (Ph-4′′), 148.82 (C-4), 159.54 
(C=O), 161.35 (C-2), 163.54 (Ph-4′); MS: (m/z) 386.05 
([M+H]
+
). Anal. Calcd for C17H12FN5O3S: C, 52.98; H, 
3.14; N, 18.17. Found: C, 52.75; H, 3.27; N, 18.43%. 
 
General procedure  for  the  synthesis  of 2-aryl-5-(2'-
(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles, 
7a-e 
To a solution of 2-(4-nitrophenylamino)-N'-
(substituted benzylidene)thiazole-4-carbohydrazide 6a-
e (10 mmol) in dimethylformamide (20 mL) was added 
(diacetoxyiodo)benzene (11 mmol) and the solution 
was stirred for 2 h. The excess solvent was evaporated 
in vacuum and the reaction mixture was poured in 
water. The solid so obtained was filtered and washed 
with petroleum ether to afford the pure compound 7a-e. 
 
2-Phenyl-5-(2'-(4-nitrophenylamino)thiazol-4'-yl)-
1,3,4-oxadiazole, 7a: m.p. 250-252ºC. Yield 78%. IR 
(KBr): 3385 cm
−1
 (N-H); 
1
H NMR (300 MHz, DMSO-d6): 
δ 7.61-7.65 (m, 3H, Ph-3'', 4'', 5''-H), 7.95 (d, 2H, J = 8.1 
Hz, Ph-2''', 6'''-H), 8.12 (s, 1H, thiazole-5'-H), 8.13-8.15 
(m, 2H, Ph-2", 6"-H), 8.25 (d, 2H, J = 8.1 Hz, Ph-3"', 
5"'-H), 11.21 (s, 1H, NH, exchangeable with D2O); 
13
C NMR (75 MHz, DMSO-d6): δ 116.39 (C-5ʹ), 124.65 
(2C, Ph-2′′′, 6′′′), 125.12 (2C, Ph-2′′, 6′′), 126.55 (2C, 
Ph-3′′, 5′′), 126.95 (Ph-4′′), 129.07 (Ph-1′′), 131.57  
(Ph-1′′′), 140.55 (CH=N), 140.57 (C-4ʹ), 141.86 (2C, Ph-
3′′′, 5′′′), 146.25 (Ph-4′′′), 156.91 (C=O), 159.92 (C-2ʹ), 
163.07 (C-5), 163.54 (C-2); MS: (m/z) 366.06 ([M+H]
+
). 
Anal. Calcd for C17H11N5O3S: C, 55.89; H, 3.03; N, 
19.17. Found: C, 56.02; H, 3.15; N, 19.49%. 
 
2-(4-Methylphenyl)-5-(2'-(4-nitrophenylamino) 
thiazol-4'-yl)-1,3,4-oxadiazole, 7b: m.p. 208-210ºC. 
Yield 85%. IR (KBr): 3378 cm
−1
 (N-H); 
1
H NMR (300 
MHz, DMSO-d6) δ 2.44 (s, 3H, CH3), 7.38 (d, 2H, J = 7.8 
Hz, Ph-3", 5"-H), 7.93 (d, 2H, J = 8.1 Hz, Ph-2"', 6"'-H), 
7.96 (s, 1H, thiazole-5'-H), 8.02 (d, 2H, J =7.8 Hz, Ph-2", 
6"-H), 8.24 (d, 2H, J = 8.1 Hz, Ph-3"', 5"'-H), 11.19  
(s, 1H, NH, exchangeable with D2O); 
13
C NMR (75 MHz, 
DMSO-d6): δ 21.19 (CH3), 116.86 (C-5ʹ), 124.59 (2C, Ph-
2′′′, 6′′′), 126.45 (2C, Ph-3′′, 5′′), 127.09 (Ph-4′′), 129.58 
(Ph-1′′), 129.73 (2C, Ph-2′′, 6′′), 135.45 (Ph-1′′′), 140.55 
(CH=N), 140.67 (C-4ʹ), 141.94 (2C, Ph-3′′′, 5′′′), 146.20 
(Ph-4′′′), 158.92 (C=O), 159.72 (C-2ʹ), 163.04 (C-5), 
163.58 (C-2); MS: (m/z) 380.05 ([M+H]
+
). Anal. Calcd 
for C18H13N5O3S: C, 56.99; H, 3.45; N, 18.46. Found: C, 
56.67; H, 3.17; N, 18.68%. 
2-(4-Chlorophenyl)-5-(2'-(4-nitrophenylamino) 
thiazol-4'-yl)-1,3,4-oxadiazole, 7c: m.p. 220-222ºC. 
Yield 82%. IR (KBr): 3394 cm
−1
 (N-H); 
1
H NMR 
(300 MHz, DMSO-d6): δ 7.62 (d, 2 H, J = 8.4 Hz, 
Ph-3", 5"-H), 7.95 (d, 2H, J = 8.1 Hz, Ph-2"', 6"'-H), 
8.08 (s, 1H, thiazole-5'-H), 8.01 (d, 2H, J = 8.4 Hz, 
Ph-2", 6"-H), 8.22 (d, 2H, J = 8.1 Hz, Ph-3"', 5"'-H), 
11.18 (s, 1H, NH, exchangeable with D2O); 
13 
C NMR 
(75 MHz, DMSO-d6): δ 116.36 (C-5ʹ), 121.89 (2C, 
Ph-3′′, 5′′), 125.03 (2C, Ph-2′′′, 6′′′), 128.11 (2C, Ph-
2′′, 6′′), 129.26 (Ph-4′′), 135.21 (Ph-1′′′), 137.08  
(Ph-1′′), 140.54 (CH=N), 140.94 (C-4ʹ), 141.92 (2C, 
Ph-3′′′, 5′′′), 146.19 (Ph-4′′′), 160.04 (C-2ʹ), 160.54 
(C=O), 162.03 (C-5), 162.80 (C-2); MS: (m/z) 400.02 
([M+H]
+
)/402.01 ([M+H+2]
+
), (3:1). Anal. Calcd For 
C17H10ClN5O3S: C, 51.07; H, 2.52; N, 17.52. Found: 
C, 51.33; H, 2.41; N, 17.81%. 
 
2-(4-Bromophenyl)-5-(2'-(4-nitrophenylamino) 
thiazol-4'-yl)-1,3,4-oxadiazole, 7d: m.p. 243-245ºC. 
Yield 80%. IR (KBr): 3382 cm
−1
 (N-H); 
1
H NMR 
(300 MHz, DMSO-d6): δ 7.79 (d, 2H, J = 8.1 Hz,  
Ph-3", 5"-H), 7.93 (d, 2H, J = 8.1 Hz, Ph-2"', 6"'-H), 
7.99 (s, 1H, thiazole-5'-H), 8.05 (d, 2H, J = 8.1 Hz, 
Ph-2", 6"-H), 8.24 (d, 2H, J = 8.1 Hz, Ph-3"', 5"'-H), 
11.21 (s, 1H, NH, exchangeable with D2O); 
13
C NMR 
(75 MHz, DMSO-d6): δ 116.39 (C-5ʹ), 122.33 (2C, 
Ph-3′′, 5′′), 125.08 (2C, Ph-2′′′, 6′′′), 125.72 (2C,  
Ph-2′′, 6′′), 128.32 (Ph-4′′), 132.26 (Ph-1′′), 132.70 
(2C, Ph-3′′′, 5′′′), 135.17 (Ph-1′′′), 140.52 (CH=N), 
140.70 (C-4ʹ), 146.22 (Ph-4′′′), 160.10 (C-2ʹ), 160.45 
(C=O), 162.81 (C-5), 163.12 (C-2); MS: (m/z) 443.98 
([M+H]
+
)/445.96 ([M+H+2]
+
), (1:1). Anal. Calcd For 
C17H10BrN5O3S: C, 45.96; H, 2.27; N, 15.76. Found: 
C, 45.94; H, 2.25; N, 15.78%. 
 
2-(4-Fluorophenyl)-5-(2'-(4-nitrophenylamino) 
thiazol-4'-yl)-1,3,4-oxadiazole, 7e: m.p. 228-230ºC. 
Yield 82%. IR (KBr): 3392 cm
−1
 (N-H); 
1
H NMR (300 
MHz, DMSO-d6): δ 7.65-7.71 (m, 2H, Ph-3", 5"-H), 
7.93 (d, 2H, J = 8.1 Hz, Ph-2"', 6"'-H), 7.99 (s, 1H, 
thiazole-5'-H), 8.03-8.07 (m, 2H, Ph-2", 6"-H), 8.24 
(d, 2H, J = 8.1 Hz, Ph-3"', 5"'-H), 11.22 (s, 1H, NH, 
exchangeable with D2O); 
13
C NMR (75 MHz, DMSO-d6): 
δ 116.36 (C-5ʹ), 120.87 (2C, Ph-3′′, 5′′), 125.07 (2C, 
Ph-2′′′, 6′′′), 128.34 (2C, Ph-2′′, 6′′), 131.46  
(Ph-1′′), 134.42 (Ph-1′′′), 140.55 (CH=N), 140.72  
(C-4ʹ), 141.94 (2C, Ph-3′′′, 5′′′), 146.25 (Ph-4′′′), 
159.54 (C=O), 160.04 (C-2ʹ), 163.08 (C-5), 163.37 
(Ph-4′′), 163.55 (C-2); MS: (m/z) 384.05 ([M+H]+). 
Anal. Calcd for C17H10FN5O3S: C, 53.26; H, 2.63; N, 
18.27. Found: C, 53.39; H, 2.69; N, 18.52%. 
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Conclusion 
In abridgement, an efficient and ecofriendly route has 
been developed for the synthesis of some new 2-aryl-5-
(2'-(4-nitrophenylamino)thiazol-4'-yl)-1,3,4-oxadiazoles 
via oxidative cyclization of 2-(4-nitrophenylamino)-N'-
arylidenethiazole-4-carbohydrazides using DIB at 
ambient temperature. This approach worked well with a 
wide variety of carbohydrazides and offered operational 
simplicity, easy work-up and efficient yields of 
unsymmetrical 1,3,4-oxadiazoles thereby extending the 
versatility of DIB in organic synthesis. 
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